Stick with FDA-approved options like sermorelin, tesamorelin, semaglutide, tirzepatide, and (where appropriate) thymosin alpha-1 compounded by legitimate pharmacies
6 Science Day Scheduling Order [PDF] 02/23/2026: Case Management Order No
17 Combination basal insulin + GLP-1 RA medications Currently, the FDA has approved two fixed-ratio combinations (FRC) of basal insulin/GLP-1 RA: insulin degludec/liraglutide, also known as iDeglira (Xultophy), and insulin glargine/lixisenatide, also known as iGlarlixi (Suliqua)
Wellbutrin (bupropion) alone does have modest appetite-suppressing effects and has been studied for weight loss off-label
Studies on hypercaloric diet-fed rats reveal that regular intake lowers oxidative stress, blood sugar, lipid profile, and obesity risk in male murine animals